Prostate cancer may be the most common non-skin cancer in the human race. Most men, if they live long enough, will develop the disease.
And yet, prostate cancer is also extremely unlikely to kill you. After five years, the survival rate is a whopping 98.6 percent. It's a paradox of medicine that we are only beginning to understand.
With prostate cancer treatment prone to significant impact to quality of life, a positive diagnosis for prostate-specific antigen, which is currently the disease's clearest marker, raises a difficult question for doctors: Is it wise to aggressively attack the tumor when treatment may be more dangerous than the disease?
With so much confusion about when to test and when to treat, the latest federal recommendations regarding prostate cancer screening from the U.S. Preventive Services Task Force (USPSTF) are incredibly important. They encourage thoughtful, informed conversations between primary care physicians and their patients in regards to the pros and cons of prostate cancer testing, and correct a dangerous trend of ignoring the disease completely.
Avoiding unnecessary risk
If prostate cancer could be treated without causing harm, every male would get tested regularly. Unfortunately, removal of tumors too often leads to impotence, incontinence and a range of other troubling outcomes, including the rare loss of life.
Because testing can also result in false positives, which can in turn lead to aggressive treatment, many men end up suffering from side effects without ever having been at risk for harm.
To help clarify such complex care situations, the U.S. Public Health Service established the USPSTF in 1984. Composed of experts in preventative medicine, the task force regularly evaluates the pros and cons of a wide range of tests and treatments, not just in cancer.
Based on the high risk of side effects that might damage quality of life, and the low risk of death from the cancer, as far back as 2008 the USPSTF recommended against screening for prostate cancer in men aged 75 or older, and in 2012 even recommended most men not get a PSA test. Sadly, in practice, those recommendations have been interpreted too bluntly.
Prostate cancer is deadly, for some
More than 28,000 Americans die from prostate cancer every year.
As an oncologic urologist, I treat prostate cancer patients daily. For those who have metastatic prostate cancer, where it spreads throughout the body, it is a terrible disease.
Recent studies have shown that since the earlier USPSTF recommendations, the number of patients diagnosed with high-risk prostate cancer the ones with advanced disease from day one have started to go up. Tragically, advanced disease is very difficult to cure.
While more data must be gathered, there appears to be an association between the national shift away from prostate cancer screening and a rise in patients diagnosed too late for us to heal them.
Thats why I'm encouraged that the USPSTF has released new draft recommendations, shifting from ruling out screening to advocating for individualized approaches, tailored to each patient, that arise from open conversations between patient and primary-care physician to address all pros and cons.
Those conversations will be important, and that shift towards recognizing the value of monitoring for some patients will encourage insurance companies to cover the test, as some had stopped doing so.
Better knowledge, better care
I regularly use robotic-assisted surgical tools and other techniques to limit side effects from prostate cancer treatment, and work with each patient and our team to develop a cancer plan that heavily weighs quality of life. However, for most prostate cancer patients, careful monitoring is still the best course of action, not treatment.
For those of us in urology, our experiences and a growing data set have convinced us that testing is critical, but the test does not dictate how to proceed. Instead, it informs decisions that also weigh each patient's individual history, genetics and wellbeing.
In the past, oncologists did not understand how to stratify prostate cancer patients according to risk, and we ended up treating too many patients who were never going to have a problem with the disease. Treatments continue to improve, as does the recognition of the critical importance of quality of life for cancer survivors.
All men should have a conversation with their primary care physician and urologist about prostate cancer, and the pros and cons of testing and treatment. With a shift away from urgent cancer removal to monitoring over time, medicine is arriving at a more balanced approach for prostate cancer. The latest USPSTF recommendations are a step in that direction, and a welcome change that, in time, will save lives.
Dr. Ahmad Shabsigh is a board-certified oncologic urologist at The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. In addition to diseases of the prostate, he treats a wide range of urological cancers.
The views expressed by contributors are their own and not the views of The Hill.
See the original post:
The latest federal guidelines on prostate cancer screenings are important - The Hill (blog)
- Utilizing your free, preventative healthcare coverage - KELOLAND.com - February 18th, 2024
- Preventive Pros: the Podcast - Department of Population and Public Health Sciences - University of Southern California - February 18th, 2024
- Heart health awareness and preventative care with Jen Lewis on Coast Live - News 3 WTKR Norfolk - February 18th, 2024
- Heart disease risk factors in women highlight need for increased awareness, prevention - American Heart Association - February 18th, 2024
- Preventive health care benefits | Opinion | thecabin.net - Log Cabin Democrat - February 18th, 2024
- Menopause and migraines: New findings point to power of prevention - Medical Xpress - February 18th, 2024
- How Young Is Too Young For Preventative Skincare? Here's What Experts Want You To Know - Health.com - February 18th, 2024
- Potential prevention of rheumatoid arthritis with injection? Clinical study brings hope for millions - WION - February 18th, 2024
- Heart disease risk factors in women highlight need for increased awareness, prevention - Medical Xpress - February 18th, 2024
- Stay on top of your fur baby's health: the importance of scheduling routine vet visits - FoxReno.com - May 17th, 2023
- Preventive healthcare - May 9th, 2023
- What Is Preventive Health and Why Is It Important? - May 9th, 2023
- What Is Preventive Medicine & Why Do We Need It? | AUC - February 16th, 2023
- Preventive Medicine | Journal | ScienceDirect.com by Elsevier - December 3rd, 2022
- Migraine - Diagnosis and treatment - Mayo Clinic - December 3rd, 2022
- Functional Medicine of Idaho | Preventative Root Cause Medicine - December 3rd, 2022
- These 2 Staten Island nurses believe IV hydration drips and vitamin shots are key to long-term health - SILive.com - December 3rd, 2022
- CNBCTV-18 and IIM-K's India@2047 Leadership Series: Challenges and opportunities in the fintech and healthcare sectors - Forbes India - December 3rd, 2022
- As N.W.T. mulls health coverage changes, petition calls for preventative HIV drug to be free - CBC.ca - September 20th, 2022
- EU regulator backs wider use of AstraZeneca COVID therapy - Reuters - September 20th, 2022
- Choose integrative medicine for health and wellness - Technique - September 20th, 2022
- The high hospital bills we make victims of rape and sexual violence pay - Vox.com - September 20th, 2022
- 4 Anti-Aging Products Youre Using All Wrong, According To Skincare Experts - SheFinds - September 20th, 2022
- Why Now is the Time to Double Down on Virtual Care - HIT Consultant - September 20th, 2022
- Tell Giselle: The price of good help is priceless - Wilkes Barre Times-Leader - September 20th, 2022
- Heron Therapeutics Announces U.S. FDA Approval of APONVIE (HTX-019) for the Prevention of Postoperative Nausea and Vomiting (PONV) - BioSpace - September 20th, 2022
- Pickleball injuries are on the rise: 5 preventive tips to keep you on the court - The Manual - September 20th, 2022
- The next big social movement and other takeaways from our regular meeting - POLITICO - September 20th, 2022
- 15 Mushrooms and How to Use Them in Vegan Cooking - VegNews - September 20th, 2022
- Use of honey in the management of Chemotherapy | CMAR - Dove Medical Press - September 20th, 2022
- Celebrity Strategy Consultant Predicts What Will Be The Most Impactful Area In The Pharmaceutical Industry - Forbes - September 20th, 2022
- C2C Care Course The Preservation of Our Global Photographic Heritage: Here, There and Everywhere - aam-us.org - August 3rd, 2022
- Loneliness: Causes, Effects And Prevention Forbes Health - Forbes - August 3rd, 2022
- Prevention and wellness is the new model, a leader from Henry Ford Health System says - Becker's Hospital Review - August 3rd, 2022
- FACT SHEET: White House Summit on Building Lasting Eviction Prevention Reform - The White House - August 3rd, 2022
- Getting Back to Employer Health and Wellness Programs - Cone Health - August 3rd, 2022
- Do ICDs Still Work in Primary Prevention Given Today's HF Meds? - Medscape - August 3rd, 2022
- Alzheimer's-defying brain offers clues to treatment, prevention - Harvard Gazette - August 3rd, 2022
- Wind-fanned lightning fire prompted precautionary evacuation notices near Medical Springs Sunday evening - Baker City Herald - August 3rd, 2022
- Experts discuss importance of cancer screenings and early detection - Merck - August 3rd, 2022
- King Institute of Preventive Medicine and Research to test samples for monkeypox - The Hindu - August 3rd, 2022
- Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations - World - ReliefWeb - August 3rd, 2022
- Dr. Sanjay Gupta: While monkeypox cases rise, why are we waiting for the cavalry to rescue us? - CNN - August 3rd, 2022
- SCYNEXIS Announces U.S. Food and Drug Administration - GlobeNewswire - August 3rd, 2022
- Governor Whitmer declares August 2022 as Breastfeeding Month, highlights additional breastfeeding observances - Michigan (.gov) - August 3rd, 2022
- New student education program supports drug and alcohol abuse prevention - The Ohio State University News - July 25th, 2022
- Suicide prevention training for health care providers a first step in longer-term efficacy - University of Washington - July 25th, 2022
- Pharmalittle: Congress may miss deadline to pass FDA user-fee bill; ViiV is urged to lower price for its HIV prevention drug - STAT - July 25th, 2022
- Prevention of Bipolar Disorder Episodes: Is It Possible? - PsychCentral.com - July 25th, 2022
- GAO Found Gap in Dirty Bomb Prevention - Government Technology - July 25th, 2022
- Florida man in apparent medical distress crashes car through beach crowd before hitting the water - CNN - July 25th, 2022
- Study: Preventive care scarce in LGBTQ+ community - - Medical Marketing and Media - July 25th, 2022
- The rise of preventive insurance purchases in India - ETHealthWorld - July 25th, 2022
- Why Are My Feet Always Cold? Cold Feet Causes and Treatment - Prevention Magazine - July 25th, 2022
- Agency looking to open overdose prevention site in Saint John amid 'poisoned' drug supply - CBC.ca - July 25th, 2022
- UVA Expert Offers Insight on the Use of Dietary Supplements for Cancer Prevention - UVA Today - July 25th, 2022
- Alzheimer's: Targeting key protein in blood may slow progression - Medical News Today - July 25th, 2022
- NPPC, FAS focused on ASF prevention in the Philippines - MEAT+POULTRY - July 25th, 2022
- Implementation of IPT in people living with HIV | RMHP - Dove Medical Press - July 25th, 2022
- NL starts preventive vaccination against monkeypox in Amsterdam, The Hague - NL Times - July 25th, 2022
- Precautionary measures you can take against brain haemorrhage - Times of India - July 25th, 2022
- Acid Reflux and Liver Disease: Signs, Symptoms and Prevention - Healthline - July 25th, 2022
- What to do if you get an allergic reaction: symptoms, causes, and prevention - Fox News - July 25th, 2022
- How one woman took control of her rare disease and achieved her dream - Times of Oman - July 25th, 2022
- Tilman Fertitta donating $50 million to UH medical school, which will be renamed after him - Houston Chronicle - May 20th, 2022
- This new 3D screensaver collection includes a driving tour of global pylons - Rock Paper Shotgun - May 20th, 2022
- Dedication, generosity and compassion that had no limit! - The Sun Chronicle - May 20th, 2022
- Manhattan internist and cardiologist, Dr. William Priester collaborates with Castle Connolly Private Health Partners to create a new concierge medical... - May 20th, 2022
- Tips on avoiding mosquitos this summer - morethanthecurve.com - May 20th, 2022
- Nanomedicine and HIV Therapeutics - AZoNano - May 20th, 2022
- The HIV Vaccine: What We Know, And What We Don't - MadameNoire - May 20th, 2022
- What we know (and don't know) about North Korea's COVID-19 outbreak - WCVB Boston - May 20th, 2022
- Experts warn of health effects from dusty conditions as sandstorm blankets UAE - Al Arabiya English - May 20th, 2022
- Statin therapy: Does the gut microbiome affect outcomes? - Medical News Today - May 20th, 2022
- New Preventative Medicine Facility Wraps Work in NYC - Healthcare Construction and Operations News - November 7th, 2021
- MPD working with faith-based leaders to fight violent crime - FOX13 Memphis - November 7th, 2021
- Cornell grad and lecturer touts benefits of plant-based diet - ithaca.com - November 7th, 2021
- Meet the Cork-born bread activist who has Goldie Hawn buying her loaves - Irish Examiner - November 7th, 2021
- Pfizer says pill cuts risk of severe Covid by 89% - RTE.ie - November 7th, 2021
- The roots of ivermectin mania: How South America incubated a fake-medicine craze that took the US by storm - Yahoo News - November 7th, 2021